BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+12.57%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$750M
AUM Growth
+$262M
(+54%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
27.81%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
137
New
15
Increased
36
Reduced
40
Closed
5
Top Buys
| 1 |
Align Technology
ALGN
|
$15.6M |
| 2 |
Elevance Health
ELV
|
$14.9M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$13.3M |
| 4 |
Amgen
AMGN
|
$11.8M |
| 5 |
Centene
CNC
|
$10.1M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$4.67M |
| 2 |
Stryker
SYK
|
$4.32M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$2.11M |
| 4 |
Becton Dickinson
BDX
|
$1.83M |
| 5 |
Zimmer Biomet
ZBH
|
$1.83M |
Sector Composition
| 1 | Healthcare | 92.09% |
| 2 | Financials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$667B
| $11.1M | 1.47% |
131,400
+96,400
| +275% | +$8.11M |
|
|
27
Zimmer Biomet
ZBH
$20.8B
| $10.7M | 1.43% |
90,640
-15,450
| -15% | -$1.83M |
|
28
Viatris
VTRS
$12B
| $10M | 1.34% |
257,200
+21,500
| +9% | +$838K |
|
29
Baxter International
BAX
$12.2B
| $9.85M | 1.31% |
190,000
| – | – |
|
30
Danaher
DHR
$141B
| $9.75M | 1.3% |
128,592
+45,120
| +54% | +$3.42M |
|
31
Cencora
COR
$57.1B
| $9.04M | 1.2% |
+102,099
| New | +$9.04M |
|
|
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
| $8.98M | 1.2% |
288,663
+278,663
| +2,787% | +$8.67M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.61M | 1.15% |
71,000
+21,600
| +44% | +$2.62M |
|
34
Vertex Pharmaceuticals
VRTX
$101B
| $8.31M | 1.11% |
76,000
-5,000
| -6% | -$547K |
|
35
Ionis Pharmaceuticals
IONS
$9.43B
| $8.25M | 1.1% |
205,253
+114,253
| +126% | +$4.59M |
|
|
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $8.14M | 1.09% |
182,725
+101,925
| +126% | +$4.54M |
|
|
ABMD
37
DELISTED
Abiomed Inc
ABMD
| $7.97M | 1.06% |
63,670
+18,620
| +41% | +$2.33M |
|
|
HZNP
38
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.37M | 0.98% |
498,765
+474,765
| +1,978% | +$7.02M |
|
39
Alnylam Pharmaceuticals
ALNY
$59.6B
| $7.27M | 0.97% |
141,900
+117,900
| +491% | +$6.04M |
|
|
HRC
40
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.22M | 0.96% |
+102,274
| New | +$7.22M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $6.93M | 0.92% |
29,000
-400
| -1% | -$95.6K |
|
42
AbbVie
ABBV
$374B
| $6.69M | 0.89% |
102,701
+87,701
| +585% | +$5.71M |
|
43
Perrigo
PRGO
$3.2B
| $6.27M | 0.84% |
94,411
+65,411
| +226% | +$4.34M |
|
|
ALR
44
DELISTED
Alere Inc
ALR
| $5.78M | 0.77% |
145,363
+97,380
| +203% | +$3.87M |
|
45
Tenet Healthcare
THC
$16.9B
| $5.77M | 0.77% |
+325,546
| New | +$5.77M |
|
46
BioMarin Pharmaceuticals
BMRN
$10.9B
| $5.71M | 0.76% |
65,000
| – | – |
|
47
MacroGenics
MGNX
$118M
| $5.67M | 0.76% |
304,597
+221,597
| +267% | +$4.12M |
|
|
EGRX
48
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.62M | 0.75% |
67,700
+27,000
| +66% | +$2.24M |
|
|
49
Becton Dickinson
BDX
$54.6B
| $5.5M | 0.73% |
30,750
-10,250
| -25% | -$1.83M |
|
|
AET
50
DELISTED
Aetna Inc
AET
| $5.43M | 0.72% |
42,600
+26,200
| +160% | +$3.34M |
|